| Date | Title | Description |
| 16.09.2024 | Asahi Kasei announces the final outcome of the public cash offer for Calliditas | Asahi Kasei announces the final outcome of the public cash offer for Calliditas
Mon, Sep 16, 2024 15:00 CET Report this content
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL ANY SHARES OR AME... |
| 07.09.2024 | 24M's $87 Million Surge: A Leap Toward Battery Revolution | In the heart of Cambridge, Massachusetts, a storm is brewing in the world of energy storage. 24M, a company that’s redefining battery technology, has just secured $87 million in Series H funding. This investment elevates its valuation to a ... |
| 07.09.2024 | 24M: Energy Storage Company Raises $87 Million (Series H Preferred Stock) At $1.3 Billion Valuation | 24M announced it had closed an $87 million investment round. This Series H Preferred Stock funding led by Nuovo+, a 24M strategic partner and licensee, values the company at $1.3 billion post-money.
The company delivers transformative batte... |
| 06.09.2024 | Asahi Kasei's Strategic Acquisition: A New Era for Calliditas Therapeutics | In a significant move that reshapes the landscape of biopharmaceuticals, Asahi Kasei Corporation has successfully completed its public cash offer for Calliditas Therapeutics AB. With a commanding 93.30% ownership of Calliditas, Asahi Kasei ... |
| 06.09.2024 | Calliditas Therapeutics: A New Chapter Begins Amidst Corporate Changes | In the world of pharmaceuticals, change is the only constant. Calliditas Therapeutics AB, a biopharmaceutical company based in Stockholm, is poised to undergo significant transformations following a recent announcement from Asahi Kasei Corp... |
| 06.09.2024 | 24M Raises $87M in Series H Funding | 24M, a Cambridge, MA-based battery innovations company, raised $87M in Series H funding, at $1.3 Billion valuation.
The round, which brought the total amount to $500M, was led by Nuovo+, with participation from Kyocera Corporation, ASAHI Ka... |
| 03.09.2024 | Notice of extraordinary meeting of Calliditas Therapeutics AB (publ) | Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)
Tue, Sep 03, 2024 12:00 CET Report this content
The shareholders of Calliditas Therapeutics AB (publ) (“Calliditas Therapeutics”), Reg. No. 556659-9766, with registered of... |
| 03.09.2024 | Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei | Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei
Tue, Sep 03, 2024 12:15 CET Report this content
Stockholm, Sweden, September 3, 2024 – Following the announcement by Asahi Kasei Corporation (“Asa... |
| 02.09.2024 | Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas | Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas
Mon, Sep 02, 2024 15:00 CET Report this content
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICI... |
| 14.08.2024 | Calliditas and Asahi Kasei: A Strategic Dance in the Biopharma Arena | In the fast-paced world of biopharmaceuticals, every move counts. Calliditas Therapeutics AB, a Swedish biopharma company, recently unveiled its interim report for the first half of 2024. The numbers tell a story of growth, challenges, and ... |
| 13.08.2024 | Calliditas Interim Report January to June 2024 | Calliditas Interim Report January to June 2024
Tue, Aug 13, 2024 07:00 CET Report this content
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX):
April to June 2024 (compared to April to June 2023) Net sales amounted to SEK... |
| 13.08.2024 | Asahi Kasei publishes a supplement to the offer document for the recommended public cash offer for Calliditas | Asahi Kasei publishes a supplement to the offer document for the recommended public cash offer for Calliditas
Tue, Aug 13, 2024 17:30 CET Report this content
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN O... |
| 06.08.2024 | Asahi Kasei Introducing the learning community “New Graduate Faculty” increases learning time for new empl oyees and reduces career anxiety | - |
| 06.08.2024 | Asahi Kasei Introducing the learning community “New Graduate Faculty” increases learning time for new empl oyees and reduces career anxiety | [Asahi Kasei] Introducing the learning community “New Graduate Faculty” increases learning time for new employees and reduces career anxiety
*Asahi Kasei Corporation*
Press release: August 6, 2024
Introducing the learning community “New Gra... |
| 31.07.2024 | Calliditas Therapeutics: Navigating Shareholder Waters Amidst Corporate Changes | In the world of finance, numbers tell stories. They pulse with the rhythm of market dynamics, reflecting the health of companies and the sentiments of investors. Calliditas Therapeutics AB, a biopharmaceutical company based in Stockholm, re... |
| 26.07.2024 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, DOMA, CALT on Behalf of Shareholders | NEW YORK, July 26, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders rela... |
| 17.07.2024 | Asahi Kasei publishes the offer document for the recommended public cash offer to the shareholders and ADS holders of Calliditas | Asahi Kasei publishes the offer document for the recommended public cash offer to the shareholders and ADS holders of Calliditas
Wed, Jul 17, 2024 17:30 CET Report this content
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY OR THE S... |
| 28.05.2024 | Asahi Kasei selected as a “DX Brand” for 4th consecutive year | Asahi Kasei Corporation
Asahi Kasei selected as a “DX Brand” for 4th consecutive year ……
Asahi Kasei Corporation (Headquarters: Chiyoda-ku, Tokyo, President: Koshiro Kudo, hereinafter referred to as the “Company”) is a digital Selected as a... |
| 28.05.2024 | Asahi Kasei selected as a “DX Brand” for 4th consecutive year | - |
| 26.02.2024 | Addionics plans $400M for U.S. battery tech factories | Addionics, a battery parts maker, announced Monday that it plans to invest $400 million in manufacturing facilities in the U.S.
Why it matters: The Inflation Reduction Act's incentives continue to lure battery companies from across the glob... |
| 25.01.2024 | Headwaters Co., Ltd. Supported Asahi Kasei’s conference DX project with “architecture introduction using Azure PaaS” and “UX development of Microsoft Teams” | Headwaters Co., Ltd.
We supported Asahi Kasei’s conference DX project with “architecture implementation using Azure PaaS” and “Microsoft Teams UX development” ……
Headwaters Co., Ltd. (Headwaters: Shinjuku-ku, Tokyo, Representative Director:... |
| 25.01.2024 | Headwaters Co., Ltd. Supported Asahi Kasei’s conference DX project with “architecture introduction using Azure PaaS” and “UX development of Microsoft Teams” | - |
| 01.11.2023 | 旭化成グリーンボンド発行に関するお知らせ | 旭化成株式会社（本社：東京都千代田区、社長：工藤 幸四郎、以下「当社」）は、国内市場において公募形式によるグリーンボンド（無担保普通社債）の発行（以下、本発行）を予定しておりますのでお知らせいたします。
本発行の背景
当社グループは、グループビジョンに掲げている「健康で快適な生活」「環境との共生」の実現を通して、社会に新たな価値を提供すべく企業活動を行っています。持続可能な社会に貢献すると同時にそれを当社グループの持続的な企業価値の向上につなげていく、2つのサステナビリテ... |
| 25.10.2023 | カーボンニュートラルに特化した「Care for Earth」投資枠の第一号案件 米国NFW社への出資参画について | 旭化成株式会社（本社：東京都千代田区、社長：工藤 幸四郎、以下「当社」）は、非石油由来（※）のレザーを開発する米国のスタートアップNFW（以下「NFW社」）へ出資参画したことをお知らせします。この出資は、当社が今年４月に設定したカーボンニュートラルに特化した「Care for Earth」投資枠の第一号案件となります。
また、当社によるNFW社への出資を契機に、当社グループ傘下のSage Automotive Interiors, Inc. (本社：米国サウスカロライナ州、... |
| 24.10.2023 | Sage Automotive Interiors Partners with US startup NFW | Panels of black MIRUM® from NFW in multiple textures and finishes.
Logo for Sage Automotive Interiors
Logo for NFW
Strategic cooperation to deliver scale in the field of plastic-free, plant-based, fully circular leather alternatives for aut... |
| 18.10.2023 | ロゼッタ、旭化成において「neurassist(ニューラアシスト)」実証実験を開始 - 独自に社内データを学習し、生成AIを事業成長に活用 - | 株式会社メタリアル（本社：東京都千代田区、代表取締役：五石 順一）子会社の株式会社ロゼッタ（代表取締役：渡邊 麻呂）は、旭化成株式会社（東京都千代田区、代表取締役社長：工藤 幸四郎）のDXを推進する部門であるデジタル共創本部において、同社の生成AIプラットフォーム『Metareal AI』の企業向けカスタマイズ版となる「neurassist (ニューラアシスト)」( https://neurassist.ai/ ) 実証実験を実施いたします。
【 実験の目的 】
「neu... |
| 17.11.2022 | Neste, Brightlands Venture Partners, 4 Impact VC and Asahi Kasei invests combined EUR 11 million into startup Circularise to accelerate a shift towards a circular economy | Neste, Brightlands Venture Partners, 4 Impact VC and Asahi Kasei invests combined EUR 11 million into startup Circularise to accelerate a shift towards a circular economy
Thu, Nov 17, 2022 09:00 CET Report this content
Neste Corporation, Ne... |
| 28.01.2022 | Asahi Kasei : Sustainability Report 2021 Part1 | Care for People,
Care for Earth
Sustainability Report 2021
Asahi Kasei Group
Asahi Kasei Group Sustainability Report 2021
INDEX
Editorial Policy
Management Message
Asahi Kasei Products and Technologies in
Everyday Life
Contribution through ... |
| 10.11.2021 | Corporate Governance Report | This document has been translated for reference purposes only from an original document submitted to the Tokyo Stock Exchange in Japanese. The original shall prevail in the event of any discrepancy between this translation and the Japanese ... |
| 09.03.2021 | Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care | CHELMSFORD, Mass. & TOKYO--(BUSINESS WIRE)--Mar 9, 2021--
Asahi Kasei Corporation, a diversified Japanese multinational, today announced that its U.S. subsidiary ZOLL Medical Corporation (“ZOLL”), a manufacturer of medical devices and r... |
| 26.01.2021 | Asahi Kasei & Archimedes Team Up to Revolutionize Hand Sanitization via HALO™ | |
| 08.09.2016 | Chrono Therapeutics raises $47.6M for smoking cessation wearable to deliver nicotine fix before you wake | The wearable also has a “crave” button users can press that records the moment they want a cigarette and triggers an immediate coaching message through the app to help the user get through the moment without smoking.
There is also a behavio... |
| - | Chrono Therapeutics raises $47.6M for smoking cessation wearable to deliver nicotine fix before you wake | Smoking cessation is a big priority for self-insured employer programs and payers, particularly since most payers are inclined to reimburse for these programs because of the impact of smoking on health. The challenge, as Chrono Therapeutics... |
